Tripeptide-copper complex GHK-Cu (II) transiently improved healing outcome in a rat model of ACL reconstruction

Anterior cruciate ligament (ACL) reconstruction is one of the most common orthopaedic procedures, and improving graft healing remains a significant clinical goal. This study by Fu, Cheuk, Chiu, and colleagues investigated whether GHK-Cu could improve healing outcomes following ACL reconstruction in a rat model.

The researchers applied the GHK-Cu tripeptide-copper complex to ACL reconstruction sites and assessed healing outcomes over time, measuring graft integration, tissue quality, and biomechanical properties. This approach tested whether the peptide's known regenerative properties could translate to improved outcomes in a clinically relevant orthopaedic procedure.

The results showed that GHK-Cu improved healing outcomes in ACL reconstruction, with treated grafts demonstrating enhanced tissue integration and repair compared to controls. While the improvement was transient, it demonstrated the peptide's capacity to positively influence ligament healing in a surgical context.

For the field of orthopaedic surgery, this study supports GHK-Cu's potential as an adjunctive therapy to improve surgical outcomes. The ability to enhance graft healing after ACL reconstruction could lead to faster rehabilitation and better long-term results for the many patients who undergo this common procedure each year.